Two Sigma Investments, LP Axonics, Inc. Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$52.6 - $67.34 $441,577 - $565,319	8,395 Added 11.47%	81,605 $4.45 Million
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $3.93 Million - $5.05 Million	-65,985 Reduced 47.4%	73,210 $4.58 Million
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $8.07 Million - $10.9 Million	139,195 New	139,195 $9.81 Million
Q2 2022 Aug 15, 2022	SELL	$39.5 - $64.42 $233,010 - $380,013	-5,899 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $1.77 Million - $2.54 Million	-40,495 Reduced 87.28%	5,899 $369,000
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $104,220 - $152,861	-2,084 Reduced 4.3%	46,394 $2.6 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $1.75 Million - $2.28 Million	-34,041 Reduced 41.25%	48,478 $3.07 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $4.05 Million - $4.94 Million	82,519 New	82,519 $4.94 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $28.96 $920,455 - $1.36 Million	-47,034 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $1.27 Million - $1.99 Million	47,034 New	47,034 $1.27 Million

233

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.